Rubius Therapeutics (NASDAQ:RUBY) Earnings Information
Rubius Therapeutics last released its quarterly earnings results on February 23rd, 2021. The reported ($0.50) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.53) by $0.03. Rubius Therapeutics has generated ($2.08) earnings per share over the last year. Rubius Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 10th, 2021 based off prior year's report dates.
Rubius Therapeutics Earnings Estimates and Actuals by Quarter
The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
Rubius Therapeutics (NASDAQ:RUBY) Earnings Estimates
2021 EPS Consensus Estimate: ($2.00)
Rubius Therapeutics (NASDAQ RUBY) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)